Repository logo
 

Endovascular versus open repair of abdominal aortic aneurysm: Very long term follow up of the United Kingdom Endovascular Aneurysm Repair 1 (EVAR 1) randomised controlled trial

Published version
Peer-reviewed

Change log

Authors

Patel, Rajesh 
Sweeting, Michael J 
Powell, Janet T 
Greenhalgh, Roger M 

Abstract

Background: Short-term survival benefits of endovascular repair (EVAR) versus open repair of intact abdominal aortic aneurysms have been shown in randomised trials, but this early survival benefit is lost within a few years. The long-term survival benefit of EVAR is unclear.

Methods: Between 1999 and 2004, 1252 patients from 37 centres with aneurysms ≥5.5cm diameter, suitable for either EVAR or open repair, were randomly assigned 1:1 to either EVAR (n=626) or open repair (n=626) using computer-generated sequences of randomly permuted blocks stratified by centre. The primary analysis compared rates of total and aneurysm-related death until mid-2015; re-interventions were a secondary outcome.

Findings: Over a mean of 12.7 years (maximum 15.8-years) of follow-up there was no evidence of a difference in total or aneurysm-related mortality between the randomised groups. An early survival benefit in the EVAR group was lost and beyond 8-years of follow-up there was increased aneurysm-related and total mortality, adjusted hazard ratios 5.82 (95%CI 1.64,20.65; p=0.006) and 1.25 (95%CI 1.00,1.56; p=0.05), respectively: the hazard ratios increased further for per-protocol analyses. The increased aneurysm-related mortality beyond 8 years was mainly attributable to secondary aneurysm sac rupture, with increased cancer mortality also observed in the EVAR group. Overall, aneurysm re-intervention rates were higher in the EVAR than in the open repair group, 4.1 and 1.7 per 100 person-years respectively, p<0.001 with re-interventions occurring throughout follow-up.

Interpretation: Early EVAR survival benefit was followed by inferior late survival and graft durability compared to open repair. Inadequate late surveillance may have contributed to these findings.

Description

Keywords

Journal Title

The Lancet

Conference Name

Journal ISSN

Volume Title

Publisher

Elsevier

Publisher DOI

Publisher URL

Sponsorship
National Institute for Health Research (UK) and Camelia Botnar Arterial Research Foundation.